A major challenge in preventing, detecting and responding to substandard and falsified (SF) medical products is the lack of accessible and reliable information on how widespread the problem is and where. SF medical products, which includes medicines, vaccines, diagnostic tests and devices, pose an i...

Nominations for members of the COVID-19 Data Platform Data Access Committee are now open. Please consider nominating individuals to contribute expertise to this pioneering collaboration in COVID-19 and emerging infections research to covid19@iddo.org by 31 July 2020.

It is with great sadness that IDDO has learnt of the passing of Professor Marleen Boelaert, a valued member of the IDDO team since 2017. Professor Boelaert’s research concentrated on the control of tropical infectious diseases, mainly leishmaniasis and sleeping sickness.

A first of its kind collaborative open access library to support the global malaria research effort is now available.

IDDO has extended the feedback period on its draft Research Agenda on schistosomiasis and soil-transmitted helminthiases (STHs) until July 17. Comments are welcome from the wider research community to help form the direction of research work using IDDO’s schistosomiasis and STHs data platform.

Visceral leishmaniasis (VL), also known as kala-azar, is transmitted to humans through the bites from infected female phlebotomine sand flies. If left untreated, it is fatal in 95% of cases. Globally, it is estimated there are up to 22,000 new cases of VL each year which occur in Brazil, Ethiopia, I...

The research, published today in The Lancet Infectious Diseases is the fruit of joint project between investigators from around the world to conduct the largest individual patient data meta-analysis to date under the WWARN umbrella. The study found that artemether-lumefantrine (AL) and other artemis...

IDDO is proud to be part of the CDISC task force who rapidly developed the newly released Interim User Guide to support the Covid-19 research community.

Recently a newly formed site team in Malawi used the WWARN Malaria Clinical Trials Toolkit for their antimalarial-antiretroviral drug-drug interaction trial with pregnant women (IMPROVE DDI).

IDDO has published a draft Research Agenda for open review on schistosomiasis and soil-transmitted helminthiases (STHs) for feedback and comments from the wider research community until June 4, 2020.

Global health experts have united in a call for governments and international organisations around the world to plan strategically for the coordinated production, equitable distribution and surveillance of COVID-19 medical products to ensure access to quality-assured medications for everyone.

A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings. The COVID-19 Clinical Research Coalition aims to accelerate desperately needed COVID-19 research i...

The problem of substandard and falsified (SF) medical products affects all countries but few regulatory authorities or pharmaceutical companies have policies of publicly releasing data.

Researchers from low and middle-income countries who work in neglected tropical diseases (NTDs) are invited to apply for a fellowship starting this autumn.

12 March 2020, Bangkok (Thailand) – Adding a third antimalarial drug to current artemisinin-combination therapies (ACTs) provides effective treatment against multidrug-resistant falciparum malaria in Southeast Asia, say Mahidol and Oxford University researchers in a study published today in The Lanc...

Simon Croft, Professor of Parasitology at the London School of Hygiene and Tropical Medicine, has been involved in visceral leishmaniasis research for 38 years. Prof Croft has been instrumental in setting up the IDDO’s visceral leishmaniasis data platform, including serving as the Chair of its Scien...

Il est désormais possible de déposer des demandes d'accès aux données sur la plate-forme de données Ebola. La plate-forme détient actuellement, sous l'autorité des gouvernements, ministères et organisations des pays touchés par le virus Ebola, des données concernant plus de 13 500 patients. Et ce no...

The Ebola Data Platform is now open for data access applications. The platform currently holds contributed data from >13,500 patients under the authority of governments, ministries, and organisations in Ebola-affected countries, and this number is increasing. Researchers can apply to access the d...

A statistical analysis of data hosted within the WWARN repository from 4,214 participants across multiple study sites in Africa has been published in BMC Medicine. Results indicate that the local prevalence of resistance-associated markers should be considered when choosing a first-line drug to ensu...